Cellectis S.A.
ALCLS.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €152 | €160 | €97 | €379 |
| - Cash | €143 | €137 | €98 | €186 |
| + Debt | €91 | €85 | €83 | €102 |
| Enterprise Value | €100 | €109 | €82 | €295 |
| Revenue | €42 | €1 | €19 | €74 |
| % Growth | 5,397.5% | -96.1% | -74.1% | – |
| Gross Profit | €42 | €0 | €17 | €38 |
| % Margin | 100% | 2.4% | 90.8% | 50.9% |
| EBITDA | -€9 | -€93 | -€76 | -€85 |
| % Margin | -22.8% | -12,269.7% | -398.4% | -115.5% |
| Net Income | -€37 | -€101 | -€99 | -€86 |
| % Margin | -88.6% | -13,385.3% | -514.8% | -116.7% |
| EPS Diluted | -0.41 | -1.92 | -2.17 | -1.93 |
| % Growth | 78.6% | 11.5% | -12.4% | – |
| Operating Cash Flow | €23 | -€25 | -€87 | -€105 |
| Capital Expenditures | -€4 | -€1 | -€2 | -€20 |
| Free Cash Flow | €19 | -€26 | -€90 | -€124 |